tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Chemed reiterates FY25 EPS guidance of $22.00-$22,30, consensus $22.15

This guidance assumes that there will be no Medicare Cap related to the company’s Florida combined program for the government FY26 beginning on October 1, 2025.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1